What is he best known for?
The fields of study he is best known for:
Wen-Hwa Lee mainly focuses on Molecular biology, Cancer research, Retinoblastoma protein, Retinoblastoma and Cell biology.
The various areas that he examines in his Molecular biology study include Regulation of gene expression, Gene, Exon, Cyclin D1 and Gene product.
He combines subjects such as DNA damage, Carcinogenesis, Stem-cell therapy, Metastasis and Breast cancer with his study of Cancer research.
He has researched Retinoblastoma protein in several fields, including CDC2 Protein Kinase, Cyclin-dependent kinase 2 and Kinase activity.
His Retinoblastoma research incorporates themes from Monoclonal antibody and SV40 large T antigen, Transfection.
His Cell biology research integrates issues from CD44 and Programmed cell death.
His most cited work include:
- The retinoblastoma protein associates with the protein phosphatase type 1 catalytic subunit. (1339 citations)
- SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene (1207 citations)
- Human retinoblastoma susceptibility gene: cloning, identification, and sequence (1202 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Molecular biology, Cancer research, Gene, Cell biology and Retinoblastoma.
His research in Molecular biology intersects with topics in Gene expression, Retinoblastoma protein, Exon, Cyclin D1 and Nuclear protein.
The Cancer research study combines topics in areas such as Cancer, Cancer cell, Carcinogenesis, Metastasis and Breast cancer.
Genetics covers Wen-Hwa Lee research in Gene.
His Cell biology research is multidisciplinary, relying on both Oxidative stress, Biochemistry, Programmed cell death and Kinetochore.
The study incorporates disciplines such as Susceptibility gene, Allele, Tumor suppressor gene, Regulation of gene expression and Antibody in addition to Retinoblastoma.
He most often published in these fields:
- Molecular biology (34.93%)
- Cancer research (42.47%)
- Gene (22.26%)
What were the highlights of his more recent work (between 2013-2021)?
- Cancer research (42.47%)
- Pancreatic cancer (10.96%)
- Cancer cell (14.38%)
In recent papers he was focusing on the following fields of study:
His main research concerns Cancer research, Pancreatic cancer, Cancer cell, Metastasis and Cancer.
His studies in Cancer research integrate themes in fields like Carcinogenesis, Tumor microenvironment, Phosphorylation, Tumor progression and Kinase.
His studies deal with areas such as Cell culture, Malignancy, Cell growth, Immunology and Small molecule as well as Cancer cell.
Wen-Hwa Lee interconnects Antibody and Bioinformatics in the investigation of issues within Cancer.
His work deals with themes such as Molecular biology and Cell biology, which intersect with Helicase.
His Molecular biology study incorporates themes from Genome instability and Homologous recombination.
Between 2013 and 2021, his most popular works were:
- CtIP-mediated resection is essential for viability and can operate independently of BRCA1 (87 citations)
- Targeting IL-17B–IL-17RB signaling with an anti–IL-17RB antibody blocks pancreatic cancer metastasis by silencing multiple chemokines (81 citations)
- Targeting IL-17B–IL-17RB signaling with an anti–IL-17RB antibody blocks pancreatic cancer metastasis by silencing multiple chemokines (81 citations)
In his most recent research, the most cited papers focused on:
Wen-Hwa Lee spends much of his time researching Cancer research, Metastasis, Circulating tumor cell, Pancreatic cancer and Cancer.
His Cancer research research incorporates themes from Epithelial–mesenchymal transition, Tumor progression, Immunology and Cancer cell.
The concepts of his Epithelial–mesenchymal transition study are interwoven with issues in Tumor microenvironment, Cell cycle, Stromal cell and CD44.
The study incorporates disciplines such as Molecular biology and Epigenetics in addition to Metastasis.
His study on Circulating tumor cell also encompasses disciplines like
- Pathology and related Ex vivo, Internal medicine and Pancreatic ductal adenocarcinoma,
- Prospective cohort study, which have a strong connection to Oncology, Progression-free survival, Epithelial cell adhesion molecule and Carcinoma.
His Cancer research is multidisciplinary, incorporating perspectives in Whole blood, Antibody and Antigen.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
